Why Mobile Eye Exams Are Critical In Clinical Trials With Ocular Endpoints

Mobile eye exams have become a critical innovation in clinical trials with ocular endpoints, addressing logistical challenges and improving patient experiences. 20/20 Onsite offers mobile vision care solutions that enhance trial efficiency and data accuracy while reducing patient burden. These solutions are particularly beneficial in trials where traditional eye care services are not routinely provided, often leading to delays and patient inconvenience.

The mobile services provided by 20/20 Onsite include three delivery models: Mobile Vision Clinics (MVC), Mobile Clinical Suites (MCS), and Mobile Vision Pods (MVP). MVCs are fully equipped optometry clinics on wheels, bringing eye care directly to patients and minimizing travel. MCS are temporary eye clinics set up at clinical trial sites, eliminating the need for patients to visit off-site specialists. MVPs offer semi-permanent clinics for trials requiring frequent patient visits, ensuring consistent and accessible care. These mobile options provide significant benefits: they streamline safety testing by conducting on-site ophthalmic assessments, reduce site staff workload through customized exam forms, and expedite data turnaround with remote ophthalmologist reviews. By minimizing travel and life interruptions for patients, 20/20 Onsite enhances participation and experience in clinical trials, particularly in underserved areas.